30 May 2023 Mithra appoints experienced life sciences executive Christian Homsy* as Chairman Member news
26 May 2023 Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema Member news
25 May 2023 The QbD Group acquires Turnstone Communications and BioVox to strengthen its specialist science communication and marketing services Member news
25 May 2023 The QbD Group acquires Michor Consulting to enhance its regulatory affairs services across Europe Member news
24 May 2023 Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis Member news
15 May 2023 Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
